Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02836418
Recruitment Status : Completed
First Posted : July 19, 2016
Last Update Posted : April 24, 2017
Sponsor:
Information provided by (Responsible Party):
aTyr Pharma, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 18, 2017
Actual Study Completion Date : April 18, 2017